Graves’ diseaseGraves’ orbitopathyManagementTreatmentTraditional systems of grading severity would identify the category of "mild" disease as that which does not require intervention, and the management of moderate and severe disease is often discussed together. There is increasing appreciation of the ...
Due to the complexity of COVID-19, experts have suggested classifying COVID-19 infection into mild, moderate, severe and critically severe types based on the clinical manifestations, CT imaging and laboratory outcomes of the patients8,9. As neither the mild type nor the moderate type belongs to...
Overall, the treatment groups showed a 40 percent decrease in OSA severity. Ten of the 16 patients in the treatment group who had originally been classified as having moderate OSA based on their apnea-hypopnea index (AHI) score were reclassified as having either mild (eight) or no OSA (two...
2022 Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19A Randomized Clinical Trial Anil Gupta, MD1; Yaneicy Gonzalez-Rojas, MD2; Erick Juarez, MD3; et al Manuel Crespo Casal, MD4; Jaynier Moya, MD5; Diego Rodrigues Falci, MD, PhD6;...
Patients with moderate condition in leritrelvir group had shorter median time to sustained clinical recovery than those in placebo (267.45 h vs. 296.65 h; difference: 29.20 h; HR: 1.22 [95% CI 1.03–1.44]; Table S13). Discussion Although the number of COVID-19 cases and casualty world...
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370(4):311–21. Article CAS Google Scholar Marder K. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;353(5):2379–88. Google Scholar Feldman HH,...
This Medical News article explores timely topics discussed at the annual IDWeek conference. Incorrect Data, Investigator Name, and eFigure JAMA Correction January 10, 2023 Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 ...
International Journal of COPD Dovepress open access to scientific and medical research Open Access Full Text Article Original Research Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment? This article was published in the following Dove ...
Conclusions Among patients with mild to moderate hypertension, treatment with a pill containing low doses of 3 antihypertensive drugs led to an increased proportion of patients achieving their target blood pressure goal vs usual care. Use of such medication as initial therapy or to replace monotherapy...
In conclusion, no clear set of variables associated with dual-task performance was found that could distinguish between the different cognitive classifications in our sample with mild to moderate PD. However, the TUG test with an added serial subtraction task seemed to be the most promising dual-...